Opaleye Management Inc. has sold 198,572 shares of Harrow (NASDAQ:HROW) over March 3 and 4, 2026, for a total of approximately $7.8 million, according to an SEC Form 4 filing. The transactions occurred at weighted average prices of $39.15 and $39.67, leaving Opaleye with an indirect stake of about 3.68 million shares, roughly 10% of Harrow’s total shares outstanding.
This sale comes shortly after Harrow’s Q4 2025 earnings report, which missed analyst expectations and triggered a significant stock drop. While the timing of the sale may raise eyebrows, it appears more to be a tactical move rather than a sign of diminished confidence in Harrow’s long-term prospects. The retained stake indicates continued institutional support, as Opaleye remains one of Harrow’s largest backers.
For market professionals, the key takeaway is that while the share sale might suggest profit-taking, Opaleye’s substantial remaining position signals ongoing commitment to Harrow, making it a potential area of interest for investors looking to gauge the stock’s resilience post-earnings.
Source: nasdaq.com